Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study will measure improvements in outcomes obtained from laboratory testing of the SHP and i-Limb from baseline to after 8 weeks of daily use. A secondary analysis will incorporate the subjects' existing prosthetic hands. Finally, surveys and usage data collected through the SHP and i-Limb firmware during daily use will complement data the aforementioned outcomes to explore factors that may be related to differences in grasping and manipulation performance.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. the individual can successfully use their prosthesis, list the components used and that their current prosthesis is fitting properly (by performing a tension analysis);
- • 2. the individual had unilateral transradial limb loss more than 6 months before the clinical evaluation because, to use a myoelectric prosthesis, the residual limb volume needs to be stable;
- • 3. the individual is a proficient owner of one or more common myoelectric prosthetic hands, such as the Sensor Hand Speed and Bebionic.
- Exclusion Criteria:
- • 1. individuals who have had transradial amputation for less than 6 months;
- • 2. individuals who have been fit and trained to use a prosthesis but chose not to use one;
- • 3. individuals who use the i-Limb Quantum myoelectric prosthesis;
- • 4. symptomatic brachial plexopathy, cervical radiculopathy or polyneuropathy (observed);
- • 5. orthopedic, joint degeneration (i.e., arthritis, self-reported) affecting the hand or cervical spine that severely limit upper limb function (observed);
- • 6. visual problems that would interfere with the grasping;
- • 7. co-existing central nervous system disease with symptoms that limit upper extremity function (e.g., multiple sclerosis, motor neuron disease, myasthenia gravis, Parkinson's disease, dystonia) revealed in medical history;
- • 8. limited range of motion as assessed through range of motion testing;
- • 9. inability to follow study instructions;
- • 10. use of medications that might affect sensory and/or motor functions.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Rochester, Minnesota, United States
Tempe, Arizona, United States
Tempe, Arizona, United States
Patients applied
Trial Officials
Marco Santello, Ph.D.
Principal Investigator
Arizona State University
Kristin D. Zhao, Ph.D.
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials